Beth Zelnick Kaufman - 12 Dec 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Legal Officer
Signature: /s/ Beth Zelnick Kaufman
Issuer symbol: CRMD
Transactions as of: 12 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Dec 2023, 16:05:32 UTC
Next filing: 16 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+50,000		$0.000000	50,000	12 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRMD	Stock Option (Right to Buy Common Stock)	Award	$0	+200,000		$0.000000	200,000	12 Dec 2023	Common Stock	200,000	$3.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These Restricted Stock Units were granted on 12/12/2023. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.
F2	These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.